116 related articles for article (PubMed ID: 6389728)
1. [Analysis of HLA-DR antigen expression on choriocarcinoma].
Yamashita K; Nakamura T; Shimizu T; Ikeda H; Katagiri M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1901-6. PubMed ID: 6389728
[TBL] [Abstract][Full Text] [Related]
2. [Studies on HLA-class I and class II antigen expression in cultured choriocarcinoma cell lines].
Yamashita K; Nakamura T; Shimizu T; Ikeda H; Katagiri M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):17-22. PubMed ID: 3512743
[TBL] [Abstract][Full Text] [Related]
3. [HLA antigens in choriocarcinoma].
Sasagawa M; Suzuki T; Kajino T; Ohno M; Kanazawa K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):81-4. PubMed ID: 6366090
[TBL] [Abstract][Full Text] [Related]
4. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line.
Ellis SA; Sargent IL; Redman CW; McMichael AJ
Immunology; 1986 Dec; 59(4):595-601. PubMed ID: 3804380
[TBL] [Abstract][Full Text] [Related]
6. Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar.
Anderson DJ; Berkowitz RS
J Immunol; 1985 Oct; 135(4):2498-501. PubMed ID: 3928751
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of HLA antigens on gynecologic cancer cells by interferon-gamma.
Okamura K; Abe Y; Yamada K; Uehara S; Yajima A
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):945-8. PubMed ID: 3090175
[TBL] [Abstract][Full Text] [Related]
8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
9. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-A, -B, and -C and beta 2-microglobulin antigens in human choriocarcinoma cell lines.
Trowsdale J; Travers P; Bodmer WF; Patillo RA
J Exp Med; 1980 Aug; 152(2 Pt 2):11s-17s. PubMed ID: 6157763
[TBL] [Abstract][Full Text] [Related]
12. An immunohistological study of HLA antigen expression by gestational choriocarcinoma.
Sunderland CA; Sasagawa M; Kanazawa K; Stirrat GM; Takeuchi S
Br J Cancer; 1985 Jun; 51(6):809-14. PubMed ID: 2408648
[TBL] [Abstract][Full Text] [Related]
13. Expression of HLA class I and class II antigens in human choriocarcinoma cell lines.
Yamashita K; Nakamura T; Shimizu T; Katagiri M; Ikeda H
Int J Gynaecol Obstet; 1986 Aug; 24(4):301-7. PubMed ID: 2878840
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistological study on HLA class II antigen expression and lymphocyte infiltration in cancer tissues of the uterine cervix].
Nakamura M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):349-56. PubMed ID: 1607758
[TBL] [Abstract][Full Text] [Related]
16. [The differentiation antigen of trophoblast expressed on trophoblastic neoplasms (choriocarcinoma and hydatidiform mole) detected by monoclonal antibodies].
Nakamura T; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):477-84. PubMed ID: 3701139
[TBL] [Abstract][Full Text] [Related]
17. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA-DR molecules in human gestational choriocarcinoma cell lines and malignant cell lines.
Takahashi H; Adachi S; Yoshiya N; Suzuki T; Kanazawa K; Takeuchi S
Placenta; 1987; 8(3):293-8. PubMed ID: 3658923
[TBL] [Abstract][Full Text] [Related]
19. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
[TBL] [Abstract][Full Text] [Related]
20. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
